RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 78 filers reported holding RELMADA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $839,281,000 | +226.7% | 22,671 | +67.6% | 0.00% | – |
| Q2 2022 | $256,916,000 | -60.5% | 13,529 | -43.9% | 0.00% | – |
| Q1 2022 | $650,999,000 | +176.4% | 24,120 | +227.8% | 0.00% | – |
| Q2 2021 | $235,530,000 | +4.5% | 7,358 | +15.0% | 0.00% | – |
| Q1 2021 | $225,344,000 | +9.8% | 6,400 | 0.0% | 0.00% | – |
| Q4 2020 | $205,248,000 | -54.2% | 6,400 | -46.2% | 0.00% | – |
| Q3 2020 | $447,678,000 | +81.9% | 11,900 | +116.4% | 0.00% | – |
| Q2 2020 | $246,125,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,270,072 | $61,269,000 | 9.93% |
| GREAT POINT PARTNERS LLC | 790,000 | $21,322,000 | 5.15% |
| ACUTA CAPITAL PARTNERS, LLC | 342,000 | $9,231,000 | 4.31% |
| COWEN AND COMPANY, LLC | 1,164,361 | $31,426,000 | 3.02% |
| Altium Capital Management LP | 206,000 | $5,560,000 | 1.86% |
| BVF INC/IL | 1,647,400 | $44,463,000 | 1.78% |
| RTW INVESTMENTS, LP | 2,540,074 | $68,557,000 | 1.42% |
| Vivo Capital, LLC | 705,882 | $19,052,000 | 1.31% |
| RA Capital Management | 2,000,000 | $53,980,000 | 1.18% |
| SPHERA FUNDS MANAGEMENT LTD. | 291,252 | $7,861,000 | 1.11% |